[HTML][HTML] Cytomegalovirus cell-mediated immunity: ready for routine use?
O Bestard, H Kaminski, L Couzi… - Transplant …, 2023 - frontierspartnerships.org
Utilizing assays that assess specific T-cell-mediated immunity against cytomegalovirus
(CMV) holds the potential to enhance personalized strategies aimed at preventing and …
(CMV) holds the potential to enhance personalized strategies aimed at preventing and …
What's New: Updates on Cytomegalovirus in Solid Organ Transplantation
AG Stewart, CN Kotton - Transplantation, 2024 - journals.lww.com
Cytomegalovirus (CMV) is one of the most common infections occurring after solid organ
transplantation. This high burden of disease, which incurs sizeable morbidity, may be …
transplantation. This high burden of disease, which incurs sizeable morbidity, may be …
Clinical risk factors and prognostic model for idiopathic inflammatory demyelinating diseases after haploidentical hematopoietic stem cell transplantation in patients …
RX Deng, YJ Wu, LP Xu, KY Liu… - American Journal of …, 2021 - Wiley Online Library
Idiopathic inflammatory demyelinating diseases (IIDDs) of the central nervous system (CNS)
are rare but serious neurological complications of haploidentical hematopoietic stem cell …
are rare but serious neurological complications of haploidentical hematopoietic stem cell …
Early immune surveillance to predict cytomegalovirus outcomes after allogeneic hematopoietic stem cell transplantation
J Xia, X Li, G Gui, J Wu, S Gong, Y Shang… - Frontiers in Cellular and …, 2022 - frontiersin.org
Background There is no method of predicting human cytomegalovirus (HCMV) outcomes in
allogeneic hematopoietic stem cell transplant recipients clinically, leading in some cases to …
allogeneic hematopoietic stem cell transplant recipients clinically, leading in some cases to …
Individualized management of cytomegalovirus in solid organ transplant recipients
H Saeed, M Thoendel… - Expert Review of Precision …, 2021 - Taylor & Francis
Introduction Cytomegalovirus (CMV) is an opportunistic infection that affects
immunocompromised solid organ transplant patients. Defining the imbalance between host …
immunocompromised solid organ transplant patients. Defining the imbalance between host …
[HTML][HTML] Utility of the Interferon-Gamma Enzyme-Linked Immunosorbent Spot Assay to Predict Risk of Cytomegalovirus Infection in Kidney Transplant Recipients
W Namsiripongpun, S Kantachuvesiri… - Transplant …, 2024 - frontierspartnerships.org
Background: Non-specific interferon-gamma (IFN-γ) enzyme-linked immunosorbent
(ELISpot) responses after solid organ transplant (SOT) and their relationship with …
(ELISpot) responses after solid organ transplant (SOT) and their relationship with …
Multicenter study of universal prophylaxis versus pre‐emptive therapy for patients at intermediate risk (R+) for CMV following heart transplantation
JB Lerman, CL Green, MR Molina… - Clinical …, 2023 - Wiley Online Library
Introduction Heart transplant (HT) recipients with prior exposure to cytomegalovirus (CMV
R+) are considered intermediate risk for CMV‐related complications. Consensus guidelines …
R+) are considered intermediate risk for CMV‐related complications. Consensus guidelines …
Could the Cytomegalovirus Viral Load Be Correlated with Cellular Rejection in Asymptomatic Heart Transplant Recipients? A Brief Report
K Mozaffari, N Givtaj, M Hesami… - Research in …, 2024 - journals.lww.com
Materials and Methods: In a cross-sectional study, 90 samples from 65 asymptomatic heart
transplant recipients scheduled for routine endomyocardial biopsy were obtained. All the …
transplant recipients scheduled for routine endomyocardial biopsy were obtained. All the …
[PDF][PDF] 鼠巨细胞病毒感染裸鼠肝脏损伤模型的建立
宋孙莉， 柴竹洁， 顾绍庆， 方圆… - Progress in Modern …, 2022 - biomed.cnjournals.com
摘要目的: 建立鼠巨细胞病毒(MCMV) 感染BALB/c 裸鼠肝脏损伤的模型. 方法: 健康SPF
级BALB/c 裸鼠10 只随机分为实验组和对照组, 每组5 只. 实验组小鼠每只经腹腔注射接种250 …
级BALB/c 裸鼠10 只随机分为实验组和对照组, 每组5 只. 实验组小鼠每只经腹腔注射接种250 …
[HTML][HTML] Cytomegalovirus infection in heart transplant recipients: Epidemiology, risk factors, and long-term outcomes from a major transplant center in the United States
BS Bisono-Garcia, ZA Yetmar, V Nair, L Brumble… - JHLT Open, 2024 - Elsevier
Background Despite the use of antiviral prophylaxis, cytomegalovirus (CMV) remains a
common opportunistic infection following heart transplantation. This study analyzes the …
common opportunistic infection following heart transplantation. This study analyzes the …